summaryandfuturedirections,1406
Complexcongenitalheartlesions,indiagnosticcatheterization,252
Complexdouble-outletventricle,inuniventricularhearts,1257–1258
Complexmultiplepregnancies,98–99
Compliance,arterialstiffnessand,1362t
Computationalfluiddynamics,foruniventricularheart,1350
Computedtomographicangiography,ofanomalousaorticoriginofacoronary
artery,874
Computedtomography,317–333
ofanomaliesoftheaorticarch,889–891,891f
cardiac,332–333,332f
incardiactumors,968,969f
Kawasakisyndromeand,987,987f
ofpulmonaryarterialsling,893
Conalseptum,945
Concordantatrioventricularconnections,10f
Conductiondisturbances,followingsurgicalcorrectionoftetralogyofFallot,
648
Conductionsystem,embryologyof,46
Conductiontissues
anatomyof,28–30,29f
inisomericatrialappendages,449
Conduitartery,endothelialfunctionin,1367–1368,1368f
Confidence,1488–1493
Confidenceintervals,413
Confluence,476
Confounding,411
CongenitalCardiacAnesthesiaSocietyDatabase,1511t–1514t
CongenitalCardiacCatheterizationProjectonOutcomes,1511t–1514t
Congenitalcardiacdisease
cardiacandnoncardiacsurgeryin,anestheticconsiderationsfor,1547–1552
fordiagnosticandinterventionalcatheterization,1551
exposureonbraindevelopment,effectsof,1552
managementof,1548–1549
monitoringandvascularaccessof,1550
postoperativecare,fast-trackingandtransitionto,1550–1551
preoperativeassessmentof,1547–1548,1548t
preparationandpreproceduralsedationof,1548
copynumbervariationin,56
diagnosticcatheterizationin,237–252
environmentalfactorsof,49–50
etiologyof
cardiacdevelopmentand,50–52
epidemiologyof,49–50
etiologyof,49–57
singlegenedefects,52–56
exercisetestingin,399–400
geneticfactorsof,49–50
genome-wideassociationstudiesin,56–57
large-scaleexomesequencingin,56
newgeneticsof,56–57
pharmacogeneticsintreatmentof,duringchildhood,1429–1440
dose-exposure-responserelationship,1430,1431f,1432t
drugbiotransformation,1431–1435
drugtransport,1433f,1435
practicalapplicationsof,1435–1438
qualityimprovementin,1505–1518
care
dataregistriesin,1510,1511t–1514t
datasourcesin,1509–1510
definingoutcomesin,1509
improvingoutcomesin,1510–1516
inimprovingoutcomes,roleoftransparency,1516–1518
modelfor,1505–1506,1506f
patientsandtheirfamilies,1505
targetsfor,1509
variationand,1506–1509,1507f–1508f
insettingofgeneticsyndromes,1407–1420
chromosomalanomalies,1407–1410,1408t
heterotaxy,1419–1420
microchromosomalanomalies,1410–1412
monogenicsyndrome,1412–1419
CongenitalCardiovascularInterventionalStudyConsortium,1511t–1514t
Congenitalcompleteatrioventricularblock,338–340,338b,339f–340f
Congenitalcoronaryanomalies,865–876
anatomyanddevelopmentof,865–868,866t,866b
anomalousaorticoriginofthecoronaryarteries,865–867,868f
duplicationofcoronaryarteries,867
ectopicoriginofthecoronaryarteriesin,865,866f–867f
solitarycoronaryartery,867–868,869f
anomalousaorticoriginofacoronaryartery,873–875,873f
anomalousoriginoftheleftcoronaryarteryfromthepulmonarytrunkas,870–872
anomalousrightcoronaryarteryfromthepulmonarytrunkas,872–873
coronaryorificialatresiaas,875–876
developmentalconsiderationsin,869–870,870f
fistulousconnectionsin,868–869
myocardialbridging,869
singlecoronaryarteriesas,875
Congenitaldiaphragmatichernia,pulmonaryhypertensionand,1386
CongenitalEvaluation,Reporting,andTrackingEndeavour,1511t–1514t
Congenitalheartdefects,1407
cardiacdefectsof,1407–1408
ingeneticsyndrome,1419t–1420t,1420
typesof,andassociatedsyndromes,1419–1420
Congenitalheartdisease(CHD),1483–1485
adultwith,inchronicmechanicalcirculatorysupport,1214
arrhythmiasinadultswith,356–357
care,healthsystemchallengesin,1521–1522,1522t
clinicalcarepathwayssupportingcareofchildrenandyoungpeoplewith,1481–1485
barriersandchallenges,1483
defining,1481
developmentandimplementation,1481–1483,1482f
safety,quality,andeffectiveness,1483
counselorself-awarenessin,165t,166–167
economicimplicationsof,185–188